COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,591 Articles (22,905 medRxiv, 8,686 bioRxiv)

Most recent first Previous |  Page 1939: Articles 19381-19390  | Next

Assessments of heavy lift UAV quadcopter drone to support COVID 19 vaccine cold chain delivery for indigenous people in remote areasin South East Asia
Adwibowo, A.
10.1101/2021.01.09.21249494 — Posted: 2021-01-12
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol
Solanich, X., Antoli, A., Padulles, N., Fanlo, M., Iriarte, A., Mitjavila, F., Capdevila, O., Molina, M., Sabater, J., Bas, J., Mensa-Vilaro, A., Niubo, J., Calvo, N., Bolivar, S., Rigo-Bonnin, R., Arregui, L., Tebe, C., Hereu, P., Videla, S., Corbella, X.
10.1101/2021.01.09.21249263 — Posted: 2021-01-12
Altered kidney function and acute kidney damage markers predict survival outcomes of COVID-19 patients: A prospective pilot study.
Temiz, M. Z., Hacibey, I., Yazar, R. O., Sevdi, M. S., Kucuk, S. H., Alkurt, G., Doganay, L., Dinler-Doganay, G., Dincer, M. M., Yuruk, E., Erkalp, K., Muslumanoglu, A. Y.
10.1101/2021.01.10.20249079 — Posted: 2021-01-12
Convergence of Comorbidity and COVID-19 Infection to Fatality: An Investigation Based on Concurrent Health Status Evaluation among the Elderly Population in Kerala
Joseph, S., Ulahannan, J. P.
10.1101/2021.01.06.20249030 — Posted: 2021-01-12
The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models
Davies, S. P., Mycroft-West, C. J., Pagani, I., Hill, H. J., Chen, Y.-H., Karlsson, R. T., Bagdonaite, I., Guimond, S. E., Stamataki, Z., Lima, M. A., Turnbull, J. E., Yang, Z., Vicenzi, E. E., Skidmore, M. A., Khanim, F., Richardson, A.
10.1101/2021.01.10.426114 — Posted: 2021-01-11
Microsecond simulation unravel the structural dynamics of SARS-CoV-2 Spike-C-terminal cytoplasmic tail (residues 1242-1273)
Kumar, P., Bhardwaj, T., Giri, R., Garg, N.
10.1101/2021.01.11.426227 — Posted: 2021-01-11
Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment
Cheng, M. H., Krieger, J. M., Kaynak, B., Arditi, M. A., Bahar, I.
10.1101/2021.01.10.426143 — Posted: 2021-01-11
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques
van Doremalen, N., Purushotham, J., Schulz, J., Holbrook, M., Bushmaker, T., Carmody, A., Port, J., Yinda, K. C., Okumura, A., Saturday, G., Amanat, F., Krammer, F., Hanley, P., Smith, B., Lovaglio, J., Anzick, S., Barbian, K., Martens, C., Gilbert, S. C., Lambe, T., Munster, V.
10.1101/2021.01.09.426058 — Posted: 2021-01-11
COVID-19 Severity Is Associated with Differential Antibody Fc-mediated Innate Immune Functions
Adeniji, O. S., Giron, L. B., Zilberstein, N. F., Shaikh, M. W., Balk, R. A., Moy, J. N., Forsyth, C. B., Keshavarzian, A., Landay, A. L., Abdel-Mohsen, M.
10.1101/2021.01.11.426209 — Posted: 2021-01-11
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination
Tscherne, A., Schwarz, J. H., Rohde, C., Kupke, A., Kalodimou, G., Limpinsel, L., Okba, N. M. A., Bosnjak, B., Sandrock, I., Halwe, S., Sauerhering, L., Printz, K., Nan, L., Duell, E., Jany, S., Freudenstein, A., Schmidt, J., Werner, A., Gellhorn, M., Kluever, M., Guggemos, W., Seilmaier, M., Wendtner, C., Foerster, R., Haagmans, B., Becker, S., Sutter, G., Volz, A.
10.1101/2021.01.09.426032 — Posted: 2021-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).